Express News | Impact Biomedical Inc - Canadian Patent Term Expires in May 2037

BreakingsOct 15 18:02

Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker Technology Targeting Inflammatory Disease

GlobeNewswireOct 15 18:00

Express News | Impact Biomedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease

BreakingsOct 15 18:00

Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation With Strong Support From Partners and Affiliates

GlobeNewswireOct 7 20:30

12 Health Care Stocks Moving In Friday's Intraday Session

BenzingaSep 28 00:31

Impact BioMedical Says Mark Suseck to Be Oper Chief and Todd Macko to Be CFO >IBO

Dow JonesSep 23 20:05